Home » Policy & public » Education » Protected: Introduction to Synthetic Biology Course

Protected: Introduction to Synthetic Biology Course

March 6, 2019

Kevin Costa

As Editor and Program Manager, Kevin leads SynBioBeta's digital media content, with the goal of telling the story of the people, companies, and ideas shaping the future with biology. Before joining SynBioBeta, Kevin managed the Synthetic Biology Engineering Research Center. His interests include public engagement, science writing, community building, and bikes!

View all posts

Click here to join our weekly newsletter. We want to hear what you think about this article. Got a tip for our news team? Write to editorial@synbiobeta.com.

Protected: Introduction to Synthetic Biology Course

Kevin Costa

Takeda Partners with Twist Bioscience to Expand Biologics Discovery Capabilities

CARB-X funds Eligo Bioscience to develop CRISPR-based therapeutics derived from bacteriophages to kill superbugs and prevent deadly infections in transplant patients

Bay Area COVID-Fighting Startup Files For $100m IPO

If Biology Can Build It, They Will Come: Ginkgo Bioworks Is Laying The Foundation For The $4 Trillion Bioeconomy

Editor’s picks

Say Goodbye To Moldy Bread: AI-Driven Biotech Startup Is Fermenting Natural Ingredients To Double Bakery Shelf Life

A 20-Minute Covid-19 Test Using Crispr Gene Editing Technology, Coming Soon To Your Doctor’s Office, Supermarket, And Workplace

Bay Area COVID-Fighting Startup Files For $100m IPO

Pharma’s Dirty Secret, And The Synthetic Biology Startup Offering A New Approach

If Biology Can Build It, They Will Come: Ginkgo Bioworks Is Laying The Foundation For The $4 Trillion Bioeconomy

A New Way Of Making DNA Is About To Revolutionize The Biotech Industry

There’s A New Fermented, Zero Calories Sugar On The Market (and It Actually Tastes Like Real Sugar)

Netflix ‘Pandemic’ Star Just Showed His Covid-19 Antibody Drug Works In Hamsters. How Quickly Could It Treat Humans?

Exploring coronavirus in virtual reality: Insights for fighting today’s pandemic—and the next

CONAMAX(TM): Promising Antibody-based Therapy Breakthroughs are Brewing at Conagen

From WTF to WFH: Building a digital backbone for faster, cheaper, better science in a decentralized world

Deep Tech Startups vs Covid-19, with Khosla Ventures, Fifty Years and SOSV

Investing In These 8 Bioeconomy Sectors Could Create Up To 1.6M Jobs Lost To COVID

Could franchises create a small-business boom in synthetic biology?

Biosyntia secures commercial in-licensing rights to natural isoflavonoids through global partnership

If Software Is Eating The World, Biology Is Going To Rebuild It: Zymergen CEO Josh Hoffman On The Coming Bioeconomy

Synthetic biology and America’s future: New opportunities for working with the U.S. government

From WTF to WFH: Building a digital backbone for faster, cheaper, better science in a decentralized world

Synthetic Biology Reports

Job opportunities

Videos

SynBioBeta Town Hall on sequencing’s vital new role in fighting pandemics: A COVID-19 update from Illumina leadership

SynBioBeta State of the Industry Town Hall with Drew Endy

COVID-19 Town Hall with Nanome: Exploring the coronavirus spike protein in 3D virtual reality

SynBioBeta State of the Industry Town Hall with James Collins

SynBioBeta State of the Industry Town Hall with George Church

SynBioBeta COVID-19 Town Hall with JCVI’s Richard Scheuermann on coronavirus immune epitopes

COVID-19 Town Hall on Ginkgo’s $25M pledge and the community’s responses

COVID-19 Town Hall on environmental sampling for coronavirus

COVID-19 Town Hall with Moderna CEO

Protected: Introduction to Synthetic Biology Course

Kevin Costa

You may also like

Editor’s picks

Synthetic Biology Reports

Job opportunities

Videos